Oklahoma Zantac expert witnesses analyze ranitidine use, NDMA exposure, and related cancer-risk questions in patient care. They often come from gastroenterology, oncology, pharmacology, and pharmacy practice within Oklahoma’s hospital networks and community clinics. Many have experience with prescribing patterns and medication safety oversight in systems like OU Health. They evaluate causation, labeling adequacy, risk communication, and clinical outcomes.